THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Vibhudutta Awasthi to Adenocarcinoma

Back to Details
This is a "connection" page, showing publications Vibhudutta Awasthi has written about Adenocarcinoma.
Vibhudutta Awasthi
Connection Strength
1.323
Adenocarcinoma
  1. A "dose on demand" Biomarker Generator for automated production of [(18)F]F(-) and [(18)F]FDG. Appl Radiat Isot. 2014 Jul; 89:167-75.
    View in: PubMed
    Score: 0.372
  2. Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft. Br J Pharmacol. 2013 Dec; 170(7):1436-48.
    View in: PubMed
    Score: 0.365
  3. The curcuminoid CLEFMA selectively induces cell death in H441 lung adenocarcinoma cells via oxidative stress. Invest New Drugs. 2012 Apr; 30(2):558-67.
    View in: PubMed
    Score: 0.298
  4. CLEFMA-an anti-proliferative curcuminoid from structure-activity relationship studies on 3,5-bis(benzylidene)-4-piperidones. Bioorg Med Chem. 2010 Aug 15; 18(16):6109-20.
    View in: PubMed
    Score: 0.288
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES